Position in QGEN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,209,163
New position
Shares Held
130,099
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $184,097,453 across 11 Diagnostics & Research names. QGEN ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
767,379 | $94,587,135 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
329,393 | $56,174,682 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
41,986 | $20,637,377 | |
| 4 | QGEN |
Qiagen N.V.
This page
|
130,099 | $5,209,163 | |
| 5 | NTRA |
Natera, Inc.
|
13,500 | $2,699,865 | |
| 6 | A |
Agilent Technologies, Inc.
|
17,105 | $1,949,627 | |
| 7 | DHR |
Danaher Corp /De/
|
6,462 | $1,225,195 | |
| 8 | DGX |
Quest Diagnostics Inc
|
4,182 | $819,588 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,209,163 | 130,099 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||